Latest Blogs

Jun 26, 2017
"It is not just for us, the health care providers, to set the vocabulary around cancer. We need to ask those whom the term affects," says Professor Bogda Koczwara. "People are not just the diseases that afflict them."
Jun 26, 2017
When a patient is prone to missing appointments, I try to remember that cancer is never easy, and it is especially difficult for those whose lives are chaotic.
Jun 26, 2017
Good communication isn’t learned overnight. It takes many years of watching and modeling mentors who are blessed with this subtle skill, as well as training and practice.
Jun 20, 2017
New immunotherapies are offering astounding responses, but my patient's remission came at the cost of debilitating toxicity. How much is too much to bear?
Subscribe to this column

ASCO Commentary

ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.

Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.
Nov 12, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. During the past six weeks I’ve had the opportunity to attend cancer meetings in four countries on three continents. In September, I represented ASCO at the annual meeting of the Chinese Society of Clinical Oncology (CSCO) in Xiamen,...
Feb 06, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. I’ve been a regular attendee of the Gastrointestinal Cancers Symposium since it began 11 years ago. This year’s meeting was among the very best with record attendance, superb educational talks and keynote lectures, multidisciplinary...